(Q44621708)

English

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

scientific article published in March 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mary Lou Clements-Mann

9

object named as

Clements-Mann ML

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Robert M. Chanock

7

object named as

Chanock RM

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Brian R. Murphy

8

object named as

Murphy BR

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Gonzalez IM

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Karron RA

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Eichelberger M

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Walsh EE

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Delagarza VW

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bennett R

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Falsey AR

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1763-1772

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus infection in north-east England

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between proved viral bronchiolitis and subsequent wheezing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute respiratory tract infection in daycare centers for older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute Lower Respiratory Illness in Elderly Patients with Respiratory Syncytial Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus or influenza?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Outbreak of respiratory syncytial virus infection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An outbreak of respiratory syncytial virus infection in an old people's home

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B Vaccination in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1 inhibitor production by human mononuclear leukocytes and leukocyte subpopulations exposed to respiratory syncytial virus: analysis and comparison with the response to influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppressed expression of ICAM-1 and LFA-1 and abrogation of leukocyte collaboration after exposure of human mononuclear leukocytes to respiratory syncytial virus in vitro. Comparison with exposure to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900527-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(99)00527-7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44621708&oldid=2029546827"